Exchange Announces Preliminary Designation of Jeonjin Bio Pharm as a Non-Compliant Disclosure Corporation Due to Disclosure Failures...
The Korea Exchange KOSDAQ Market Division announced on the 11th that it has given advance notice of designation as an unfaithful disclosure corporation to Jeonjin Bio Pharm due to failure to disclose and reversal of disclosure.
The deadline for the decision is the 5th of next month.
Hot Picks Today
"450,000 Deaths Expected by Early Next Year"... World's Worst-Ever El Nino Forecast Spurs Global Alarm
- "Much Has Changed Since You Left, Please Come Back"... Amazon Surprises by Actively Rehiring Former Employees
- Husband Gave 2 Million Won to His Parents, Only a 100,000 Won Gift to Wife’s Family... Divorce Lawsuit Follows
- "It's Nothing to Kill You"... Seungri Caught on CCTV Swinging Soju Bottle
- 'Terror at 2:40 a.m.'... Suspects Wrecked and Fled After an Hour in Bundang Chinese Restaurant Ordeal
The details include 5 cases of disclosure reversal and 1 case of failure to disclose.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
